FRAT2 and neoplasm: Here, we present evidence that miR-3648 is a potential tumour suppressor that directly targets FRAT1-FRAT2 (frequently rearranged in advanced T-cell lymphomas-1 and 2) to inactivate the Wnt/β-catenin pathway.